Prevalence Rates of Uterine Cervical Carcinoma in situ for Women Using the Diaphragm or Contraceptive Oral Steroids

Study of the prevalence rates of uterine cervical carcinoma in situ among women attending centres of Planned Parenthood of New York City, Inc., showed a small but statistically significant difference between the population choosing and using the diaphragm and the population choosing and using oral s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMJ 1969-07, Vol.3 (5664), p.195-200
Hauptverfasser: Melamed, Myron R., Koss, Leopold G., Flehinger, Betty J., Kelisky, Richard P., Dubrow, Hilliard
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 200
container_issue 5664
container_start_page 195
container_title BMJ
container_volume 3
creator Melamed, Myron R.
Koss, Leopold G.
Flehinger, Betty J.
Kelisky, Richard P.
Dubrow, Hilliard
description Study of the prevalence rates of uterine cervical carcinoma in situ among women attending centres of Planned Parenthood of New York City, Inc., showed a small but statistically significant difference between the population choosing and using the diaphragm and the population choosing and using oral steroids for contraception. This can be attributed either to a decreased prevalence rate for women using the diaphragm or to an increased rate for women using oral steroids. The reason for the difference is not apparent from these data.
doi_str_mv 10.1136/bmj.3.5664.195
format Article
fullrecord <record><control><sourceid>jstor_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1984009</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>20377152</jstor_id><sourcerecordid>20377152</sourcerecordid><originalsourceid>FETCH-LOGICAL-b507t-3194a58057fd3751ad870b1ce76ef0090e24d6a64dcbe066bacfe4423aa633ca3</originalsourceid><addsrcrecordid>eNqFkc2P0zAQxS0EWqplr9yQLHHikGDHX8kFCWUXFrGwaNkCN8txJq1LExfbreC_x1WrAidOlvV78-ZpHkJPKSkpZfJlN65KVgopeUkb8QDNKJd1IWrGHqIZIUQVlHP1GF3EuMrfiqm6kfwMnQnVVJI0MxQ_BdiZNUwW8J1JELEf8DxBcBPgFsLOWbPGrQnWTX402E04urTFgw_4qx9hwvPopgVOS8CXzmyWwSxGnGHrpxSMhU1yO8C3Ibt8zrbe9fEJejSYdYSL43uO5m-u7tvr4ub27bv29U3RCaJSwWjDjaiJUEPPlKCmrxXpqAUlYSCkIVDxXhrJe9sBkbIzdgDOK2aMZMwado5eHXw3226E3sI-0VpvghtN-KW9cfpfMrmlXvidpk3N84Js8PxoEPyPLcSkV34bppxZU6Xy_QRtSFaVB5UNPsYAw2kDJXpfk841aab3NWVrkQee_Z3rJD-W8oevYvLhhCvClKKiyrw4cBcT_DxxE75rqfKl9McvrVbfPojLu_tr_T7rXxz0-xz_yfYbkom1pA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1776095190</pqid></control><display><type>article</type><title>Prevalence Rates of Uterine Cervical Carcinoma in situ for Women Using the Diaphragm or Contraceptive Oral Steroids</title><source>MEDLINE</source><source>Jstor Complete Legacy</source><source>PubMed Central</source><creator>Melamed, Myron R. ; Koss, Leopold G. ; Flehinger, Betty J. ; Kelisky, Richard P. ; Dubrow, Hilliard</creator><creatorcontrib>Melamed, Myron R. ; Koss, Leopold G. ; Flehinger, Betty J. ; Kelisky, Richard P. ; Dubrow, Hilliard</creatorcontrib><description>Study of the prevalence rates of uterine cervical carcinoma in situ among women attending centres of Planned Parenthood of New York City, Inc., showed a small but statistically significant difference between the population choosing and using the diaphragm and the population choosing and using oral steroids for contraception. This can be attributed either to a decreased prevalence rate for women using the diaphragm or to an increased rate for women using oral steroids. The reason for the difference is not apparent from these data.</description><identifier>ISSN: 0007-1447</identifier><identifier>ISSN: 0959-8138</identifier><identifier>EISSN: 1468-5833</identifier><identifier>DOI: 10.1136/bmj.3.5664.195</identifier><identifier>PMID: 5792609</identifier><language>eng</language><publisher>England: British Medical Journal Publishing Group</publisher><subject>Adolescent ; Adult ; Age Factors ; Biopsies ; Birth control ; Carcinoma ; Carcinoma in situ ; Contraception ; Contraceptive Devices - adverse effects ; Contraceptives, Oral - adverse effects ; Cytology ; Estrogens - adverse effects ; Female ; Health Surveys ; Humans ; Middle Aged ; New York City ; Papers and Originals ; Parenthood ; Patient assessment ; Pregnancy ; Progestins - adverse effects ; Steroids ; Uterine Cervical Neoplasms - epidemiology ; Uterine Cervical Neoplasms - etiology ; Uterine Cervical Neoplasms - pathology ; Vaginal diaphragms</subject><ispartof>BMJ, 1969-07, Vol.3 (5664), p.195-200</ispartof><rights>Copyright 1969 British Medical Journal</rights><rights>Copyright BMJ Publishing Group LTD Jul 26, 1969</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b507t-3194a58057fd3751ad870b1ce76ef0090e24d6a64dcbe066bacfe4423aa633ca3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/20377152$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/20377152$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>230,314,724,777,781,800,882,27905,27906,53772,53774,57998,58231</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/5792609$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Melamed, Myron R.</creatorcontrib><creatorcontrib>Koss, Leopold G.</creatorcontrib><creatorcontrib>Flehinger, Betty J.</creatorcontrib><creatorcontrib>Kelisky, Richard P.</creatorcontrib><creatorcontrib>Dubrow, Hilliard</creatorcontrib><title>Prevalence Rates of Uterine Cervical Carcinoma in situ for Women Using the Diaphragm or Contraceptive Oral Steroids</title><title>BMJ</title><addtitle>Br Med J</addtitle><description>Study of the prevalence rates of uterine cervical carcinoma in situ among women attending centres of Planned Parenthood of New York City, Inc., showed a small but statistically significant difference between the population choosing and using the diaphragm and the population choosing and using oral steroids for contraception. This can be attributed either to a decreased prevalence rate for women using the diaphragm or to an increased rate for women using oral steroids. The reason for the difference is not apparent from these data.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Age Factors</subject><subject>Biopsies</subject><subject>Birth control</subject><subject>Carcinoma</subject><subject>Carcinoma in situ</subject><subject>Contraception</subject><subject>Contraceptive Devices - adverse effects</subject><subject>Contraceptives, Oral - adverse effects</subject><subject>Cytology</subject><subject>Estrogens - adverse effects</subject><subject>Female</subject><subject>Health Surveys</subject><subject>Humans</subject><subject>Middle Aged</subject><subject>New York City</subject><subject>Papers and Originals</subject><subject>Parenthood</subject><subject>Patient assessment</subject><subject>Pregnancy</subject><subject>Progestins - adverse effects</subject><subject>Steroids</subject><subject>Uterine Cervical Neoplasms - epidemiology</subject><subject>Uterine Cervical Neoplasms - etiology</subject><subject>Uterine Cervical Neoplasms - pathology</subject><subject>Vaginal diaphragms</subject><issn>0007-1447</issn><issn>0959-8138</issn><issn>1468-5833</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1969</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqFkc2P0zAQxS0EWqplr9yQLHHikGDHX8kFCWUXFrGwaNkCN8txJq1LExfbreC_x1WrAidOlvV78-ZpHkJPKSkpZfJlN65KVgopeUkb8QDNKJd1IWrGHqIZIUQVlHP1GF3EuMrfiqm6kfwMnQnVVJI0MxQ_BdiZNUwW8J1JELEf8DxBcBPgFsLOWbPGrQnWTX402E04urTFgw_4qx9hwvPopgVOS8CXzmyWwSxGnGHrpxSMhU1yO8C3Ibt8zrbe9fEJejSYdYSL43uO5m-u7tvr4ub27bv29U3RCaJSwWjDjaiJUEPPlKCmrxXpqAUlYSCkIVDxXhrJe9sBkbIzdgDOK2aMZMwado5eHXw3226E3sI-0VpvghtN-KW9cfpfMrmlXvidpk3N84Js8PxoEPyPLcSkV34bppxZU6Xy_QRtSFaVB5UNPsYAw2kDJXpfk841aab3NWVrkQee_Z3rJD-W8oevYvLhhCvClKKiyrw4cBcT_DxxE75rqfKl9McvrVbfPojLu_tr_T7rXxz0-xz_yfYbkom1pA</recordid><startdate>19690726</startdate><enddate>19690726</enddate><creator>Melamed, Myron R.</creator><creator>Koss, Leopold G.</creator><creator>Flehinger, Betty J.</creator><creator>Kelisky, Richard P.</creator><creator>Dubrow, Hilliard</creator><general>British Medical Journal Publishing Group</general><general>British Medical Association</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope></search><sort><creationdate>19690726</creationdate><title>Prevalence Rates of Uterine Cervical Carcinoma in situ for Women Using the Diaphragm or Contraceptive Oral Steroids</title><author>Melamed, Myron R. ; Koss, Leopold G. ; Flehinger, Betty J. ; Kelisky, Richard P. ; Dubrow, Hilliard</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b507t-3194a58057fd3751ad870b1ce76ef0090e24d6a64dcbe066bacfe4423aa633ca3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1969</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Age Factors</topic><topic>Biopsies</topic><topic>Birth control</topic><topic>Carcinoma</topic><topic>Carcinoma in situ</topic><topic>Contraception</topic><topic>Contraceptive Devices - adverse effects</topic><topic>Contraceptives, Oral - adverse effects</topic><topic>Cytology</topic><topic>Estrogens - adverse effects</topic><topic>Female</topic><topic>Health Surveys</topic><topic>Humans</topic><topic>Middle Aged</topic><topic>New York City</topic><topic>Papers and Originals</topic><topic>Parenthood</topic><topic>Patient assessment</topic><topic>Pregnancy</topic><topic>Progestins - adverse effects</topic><topic>Steroids</topic><topic>Uterine Cervical Neoplasms - epidemiology</topic><topic>Uterine Cervical Neoplasms - etiology</topic><topic>Uterine Cervical Neoplasms - pathology</topic><topic>Vaginal diaphragms</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Melamed, Myron R.</creatorcontrib><creatorcontrib>Koss, Leopold G.</creatorcontrib><creatorcontrib>Flehinger, Betty J.</creatorcontrib><creatorcontrib>Kelisky, Richard P.</creatorcontrib><creatorcontrib>Dubrow, Hilliard</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Proquest Nursing &amp; Allied Health Source</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BMJ</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Melamed, Myron R.</au><au>Koss, Leopold G.</au><au>Flehinger, Betty J.</au><au>Kelisky, Richard P.</au><au>Dubrow, Hilliard</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence Rates of Uterine Cervical Carcinoma in situ for Women Using the Diaphragm or Contraceptive Oral Steroids</atitle><jtitle>BMJ</jtitle><addtitle>Br Med J</addtitle><date>1969-07-26</date><risdate>1969</risdate><volume>3</volume><issue>5664</issue><spage>195</spage><epage>200</epage><pages>195-200</pages><issn>0007-1447</issn><issn>0959-8138</issn><eissn>1468-5833</eissn><abstract>Study of the prevalence rates of uterine cervical carcinoma in situ among women attending centres of Planned Parenthood of New York City, Inc., showed a small but statistically significant difference between the population choosing and using the diaphragm and the population choosing and using oral steroids for contraception. This can be attributed either to a decreased prevalence rate for women using the diaphragm or to an increased rate for women using oral steroids. The reason for the difference is not apparent from these data.</abstract><cop>England</cop><pub>British Medical Journal Publishing Group</pub><pmid>5792609</pmid><doi>10.1136/bmj.3.5664.195</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-1447
ispartof BMJ, 1969-07, Vol.3 (5664), p.195-200
issn 0007-1447
0959-8138
1468-5833
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1984009
source MEDLINE; Jstor Complete Legacy; PubMed Central
subjects Adolescent
Adult
Age Factors
Biopsies
Birth control
Carcinoma
Carcinoma in situ
Contraception
Contraceptive Devices - adverse effects
Contraceptives, Oral - adverse effects
Cytology
Estrogens - adverse effects
Female
Health Surveys
Humans
Middle Aged
New York City
Papers and Originals
Parenthood
Patient assessment
Pregnancy
Progestins - adverse effects
Steroids
Uterine Cervical Neoplasms - epidemiology
Uterine Cervical Neoplasms - etiology
Uterine Cervical Neoplasms - pathology
Vaginal diaphragms
title Prevalence Rates of Uterine Cervical Carcinoma in situ for Women Using the Diaphragm or Contraceptive Oral Steroids
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T22%3A48%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20Rates%20of%20Uterine%20Cervical%20Carcinoma%20in%20situ%20for%20Women%20Using%20the%20Diaphragm%20or%20Contraceptive%20Oral%20Steroids&rft.jtitle=BMJ&rft.au=Melamed,%20Myron%20R.&rft.date=1969-07-26&rft.volume=3&rft.issue=5664&rft.spage=195&rft.epage=200&rft.pages=195-200&rft.issn=0007-1447&rft.eissn=1468-5833&rft_id=info:doi/10.1136/bmj.3.5664.195&rft_dat=%3Cjstor_pubme%3E20377152%3C/jstor_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1776095190&rft_id=info:pmid/5792609&rft_jstor_id=20377152&rfr_iscdi=true